ATE442364T1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number: ATE442364T1
Authority: AT; Austria
Prior art keywords: crystalline form; linezolide; linezolid; preparation; relates
Prior art date: 2003-10-16

Application number

AT03769887T

Other languages

English (en)

Inventor

Rao Dodda Mohan

Reddy Pingili Krishna

Original Assignee

Symed Labs Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-16

Filing date

2003-10-16

Publication date

2009-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-16 Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE442364T1 publication Critical patent/ATE442364T1/de

Links

TYZROVQLWOKYKF-ZDUSSCGKSA-N linezolid Chemical compound O=C1O[C@@H](CNC(=O)C)CN1C(C=C1F)=CC=C1N1CCOCC1 TYZROVQLWOKYKF-ZDUSSCGKSA-N 0.000 title abstract 2
229960003907 linezolid Drugs 0.000 title abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Photoreceptors In Electrophotography (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT03769887T 2003-10-16 2003-10-16 Kristalline form von linezolid ATE442364T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000336 WO2005035530A1 (en)	2003-10-16	2003-10-16	A novel crystalline form of linezolid

Publications (1)

Publication Number	Publication Date
ATE442364T1 true ATE442364T1 (de)	2009-09-15

Family

ID=34430675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03769887T ATE442364T1 (de)	2003-10-16	2003-10-16	Kristalline form von linezolid

Country Status (10)

Country	Link
US (4)	US7714128B2 (de)
EP (3)	EP2902386B1 (de)
AT (1)	ATE442364T1 (de)
AU (1)	AU2003278592A1 (de)
DE (2)	DE60329237D1 (de)
DK (1)	DK1673370T3 (de)
ES (3)	ES2331454T1 (de)
HU (1)	HUE051230T2 (de)
PT (1)	PT1673370E (de)
WO (1)	WO2005035530A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE442364T1 (de)	2003-10-16	2009-09-15	Symed Labs Ltd	Kristalline form von linezolid
PL1737850T3 (pl)	2004-04-19	2008-02-29	Symed Labs Ltd	Nowy sposób wytwarzania linezolidu i związków pokrewnych
US20060142283A1 (en) *	2004-06-29	2006-06-29	Judith Aronhime	Crystalline form IV of linezolid
MX2007000084A (es) *	2004-06-29	2007-06-14	Teva Pharma	Formas solidas de linezolid y procesos para la preparacion delas mismas.
CA2602073A1 (en)	2005-02-24	2006-08-31	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of linezolid intermediate
US20070020329A1 (en) *	2005-07-20	2007-01-25	Ruth Tenengauzer	Methods of formulating linezolid
IT1390957B1 (it) *	2008-07-07	2011-10-27	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
EP2033960A3 (de)	2007-09-04	2009-04-29	Dipharma Francis S.r.l.	Kristalline Linezolidhydratform und Linezolidsalze
US20090093631A1 (en) *	2007-09-06	2009-04-09	Ben-Zion Dolitzky	Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) *	2008-05-14	2009-11-19	Dr. Reddy's Laboratories Ltd.	Linezolid co-crystals
EP2493867A1 (de)	2009-10-28	2012-09-05	Synthon BV	Verfahren zur herstellung einer kristallinen form von linezolid
WO2011050826A1 (en)	2009-10-28	2011-05-05	Synthon B.V.	Process for making crystalline form a of linezolid
US20130137864A1 (en)	2009-12-26	2013-05-30	Jayaraman Venkat Raman	Process for the preparation of linezolid
EP2603505A1 (de)	2010-08-11	2013-06-19	Synthon BV	Verfahren zur herstellung von linezolid
EP2690100A1 (de)	2010-08-11	2014-01-29	Synhton B.V.	Verfahren zur Linezpolid Herstellung
WO2012029074A2 (en)	2010-09-02	2012-03-08	Hetero Research Foundation	Pharmaceutical compositions of linezolid
CN102070548B (zh) *	2011-01-13	2012-12-26	浙江新东港药业股份有限公司	一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
EP2593440A1 (de)	2011-02-24	2013-05-22	Lee Pharma Limited	Kristalline form ii von wasserfreiem linezolid
EP2683696A1 (de)	2011-03-09	2014-01-15	Synthon BV	Verfahren zur herstellung einer kristallinen form von linezolid
CN102766106A (zh) *	2011-05-03	2012-11-07	江苏豪森医药集团有限公司	利奈唑胺的新晶型及其制备方法
ITMI20111311A1 (it) *	2011-07-14	2013-01-15	Dipharma Francis Srl	Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) *	2011-09-19	2013-05-23	Cadila Healthcare Limited	Process for the preparation of crystalline linezolid
WO2013093751A1 (en) *	2011-12-24	2013-06-27	Alembic Pharmaceuticals Limited	Packaging for linezolid
EP2852580A1 (de)	2012-01-24	2015-04-01	Jubilant Life Sciences Ltd.	Verbessertes verfahren zur herstellung von stabiler kristalliner form-i von linezolid, im wesentlichen frei von lösungsmittelresten
WO2013120496A1 (en)	2012-02-14	2013-08-22	Pharmathen S.A.	Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) *	2012-06-19	2013-12-27	Symed Labs Limited	Improved processes for the preparation of linezolid crystalline form iii
US9492459B2 (en) *	2012-08-10	2016-11-15	Indoco Remedies Limited	Pharmaceutical composition of linezolid
WO2014071990A1 (en)	2012-11-09	2014-05-15	Synthon Bv	Process for making linezolid
WO2014118809A1 (en)	2013-01-29	2014-08-07	Actavis Group Ptc Ehf.	Pharmaceutical composition with linezolid
IN2013MU03508A (de)	2013-11-06	2015-07-24	Unimark Remedies Ltd
CN105254580B (zh) *	2014-04-22	2018-01-02	江苏豪森药业集团有限公司	利奈唑胺晶型的制备方法
IN2015CH00214A (de) *	2015-01-13	2015-04-24	Nosch Labs Private Ltd
WO2018051360A1 (en) *	2016-09-16	2018-03-22	Lee Pharma Limited	A novel process for the preparation of crystalline linezolid form-iii
JP7101694B2 (ja)	2016-11-16	2022-07-15	ペルシカファーマシューティカルズリミテッド	腰痛のための抗生物質製剤
WO2019097242A1 (en)	2017-11-16	2019-05-23	Persica Pharmaceuticals Ltd.	Linezolid formulations
CN110194750A (zh) *	2019-06-19	2019-09-03	四川美大康华康药业有限公司	一种利奈唑胺的制备方法及精制方法
EP4415722A1 (de)	2021-10-12	2024-08-21	Persica Pharmaceuticals Ltd.	Behandlung von rückenschmerzen

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US583870A (en) *		1897-06-01		Wrench
DE2810349A1 (de)	1978-03-10	1979-09-20	Kali Chemie Pharma Gmbh	Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr)	1978-06-09	1982-12-03	Delalande Sa	Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en)	1980-10-23	1982-07-20	E. I. Du Pont De Nemours And Company	3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr)	1986-12-19	1989-04-28	Delalande Sa	Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) *	1988-10-31	1991-04-09	Otsuka Pharmaceutical Co., Ltd.	Carbostyril derivatives
DE9310451U1 (de)	1993-03-05	1994-06-30	Landis & Gyr Business Support Ag, Zug	Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
DE59306401D1 (de)	1993-03-11	1997-06-12	Landis & Gyr Tech Innovat	Brennerregler
MY115155A (en) *	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en)	1994-08-16	1997-11-18	Pharmacia & Upjohn Company	Substituted oxazine and thiazine oxazolidinone antimicrobials
PT892792E (pt) *	1996-04-11	2002-05-31	Upjohn Co	Processo para a preparacao de oxazolidinonas
EP0890791A1 (de)	1997-07-11	1999-01-13	Electrowatt Technology Innovation AG	Steuer- und Regelgerät für einen Brenner
CA2304100A1 (en)	1997-11-07	1999-05-20	Pharmacia & Upjohn Company	Process to produce oxazolidinones
AR027261A1 (es) *	2000-02-02	2003-03-19	Upjohn Co	Linezolid forma cristalina ii
US6444813B2 (en) *	2000-02-02	2002-09-03	Pharmacia & Upjohn Company	Linezolid-crystal form II
MY127336A (en)	2000-03-22	2006-11-30	Upjohn Co	Container for linezolid iv solution
DE10037585A1 (de) *	2000-08-02	2002-02-14	Valeo Schalter & Sensoren Gmbh	Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
MXPA03001337A (es) *	2000-08-14	2005-06-30	Teva Pharma	Preparacion de risperidona.
EP1365739A1 (de) *	2001-02-05	2003-12-03	Pharmacia & Upjohn Company	Zusammensetzung für die rektale applikation eines antibakteriellen oxazolidinon-arzneimittels
EP1380121B1 (de) *	2001-04-20	2007-09-26	Pharmacia & Upjohn Company LLC	Verfahren zur herstellung von oxazolidinonen
CN1155585C (zh)	2001-12-19	2004-06-30	中国医学科学院医药生物技术研究所	3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) *	2002-08-09	2006-01-31	Cephalon France	Modafinil polymorphic forms
ATE442364T1 (de)	2003-10-16	2009-09-15	Symed Labs Ltd	Kristalline form von linezolid
PL1737850T3 (pl)	2004-04-19	2008-02-29	Symed Labs Ltd	Nowy sposób wytwarzania linezolidu i związków pokrewnych
US20060142283A1 (en) *	2004-06-29	2006-06-29	Judith Aronhime	Crystalline form IV of linezolid
WO2006008754A1 (en)	2004-07-20	2006-01-26	Symed Labs Limited	Novel intermediates for linezolid and related compounds

2003
- 2003-10-16 AT AT03769887T patent/ATE442364T1/de active
- 2003-10-16 HU HUE15155714A patent/HUE051230T2/hu unknown
- 2003-10-16 ES ES09163348T patent/ES2331454T1/es active Pending
- 2003-10-16 EP EP15155714.7A patent/EP2902386B1/de not_active Expired - Lifetime
- 2003-10-16 DE DE60329237T patent/DE60329237D1/de not_active Expired - Lifetime
- 2003-10-16 ES ES15155714T patent/ES2803516T3/es not_active Expired - Lifetime
- 2003-10-16 DE DE2009163348 patent/DE09163348T1/de active Pending
- 2003-10-16 US US10/524,478 patent/US7714128B2/en not_active Expired - Lifetime
- 2003-10-16 EP EP20090163348 patent/EP2100884A1/de not_active Withdrawn
- 2003-10-16 AU AU2003278592A patent/AU2003278592A1/en not_active Abandoned
- 2003-10-16 DK DK03769887T patent/DK1673370T3/da active
- 2003-10-16 EP EP03769887A patent/EP1673370B1/de not_active Revoked
- 2003-10-16 WO PCT/IN2003/000336 patent/WO2005035530A1/en not_active Ceased
- 2003-10-16 ES ES03769887T patent/ES2331001T3/es not_active Expired - Lifetime
- 2003-10-16 PT PT03769887T patent/PT1673370E/pt unknown
2007
- 2007-09-26 US US11/861,406 patent/US7732597B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,433 patent/US7718800B2/en not_active Expired - Fee Related
- 2007-09-26 US US11/861,340 patent/US7718799B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP2902386B1 (de)	2020-04-08
DE09163348T1 (de)	2010-01-07
DK1673370T3 (da)	2009-12-07
ES2331454T1 (es)	2010-01-05
US20080090820A1 (en)	2008-04-17
EP1673370B1 (de)	2009-09-09
HUE051230T2 (hu)	2021-03-01
US20060128703A1 (en)	2006-06-15
WO2005035530A1 (en)	2005-04-21
AU2003278592A1 (en)	2005-04-27
ES2331001T3 (es)	2009-12-18
US7732597B2 (en)	2010-06-08
ES2803516T3 (es)	2021-01-27
US20080090824A1 (en)	2008-04-17
US7718800B2 (en)	2010-05-18
PT1673370E (pt)	2009-11-05
EP2902386A1 (de)	2015-08-05
US7714128B2 (en)	2010-05-11
EP1673370A1 (de)	2006-06-28
US20080091011A1 (en)	2008-04-17
US7718799B2 (en)	2010-05-18
EP2100884A1 (de)	2009-09-16
DE60329237D1 (de)	2009-10-22

Legal Events

Date

Code

Title

Description

2010-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1673370

Country of ref document: EP

Publication	Publication Date	Title
DE60329237D1 (de)	2009-10-22	Kristalline form von linezolid
DE60315368D1 (de)	2007-09-20	Korrektur des Weissabgleichs
CO5611137A2 (es)	2006-02-28	Composiciones de clorhidrato de naltrexona
CY2013036I1 (el)	2015-12-09	Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DE60333020D1 (de)	2010-07-29	Anzeigeeinrichtung des dünnen typs
EP1633307A4 (de)	2009-06-24	Modulation der survivin-expression
NO20071642L (no)	2007-06-01	N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
ECSP095220A (es)	2009-08-28	Derivados de n-fenil-2-pirimidin-amina
EA200700255A1 (ru)	2007-06-29	Новый карбамилированный еро и способ его получения
IS7806A (is)	2005-04-18	Ónæmisvaldandi samsetning
DK1603524T3 (da)	2011-11-21	Enzymholdig oral sammensætning med forbedret stabilitet
IS7716A (is)	2005-02-24	Hringlaga heterósambönd
DK1613304T3 (da)	2008-01-21	DPP-IV-inhibitorer
ATE428701T1 (de)	2009-05-15	Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
DE60333311D1 (de)	2010-08-19	Kosmetische zusammensetzung
DK1255754T3 (da)	2005-08-22	Linezolid-krystalform II
DK1380121T3 (da)	2007-12-27	Fremgangsmåde til fremstilling af oxazolidinoner
BR0307071A (pt)	2004-12-28	ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
ATE491814T1 (de)	2011-01-15	Herstellung von titanoxid
DE60333205D1 (de)	2010-08-12	Histaminika zur behandlung von allergischer rhinitis
DE60201084D1 (de)	2004-09-30	Herstellung von cyclischen esteroligomeren
ATE444290T1 (de)	2009-10-15	Oxazolderivate von tetracyclinen
DE602004023786D1 (de)	2009-12-10	Herstellung von hochreinem Alkylgallium
ATE527280T1 (de)	2011-10-15	Fluoreszentprotein und chromoprotein
DE60328456D1 (de)	2009-09-03	Eine kontinuierliche zellinie zur herstellung von impfstoffen